Drug Shortage Report for MYLAN-RISPERIDONE
Report ID | 9045 |
Drug Identification Number | 02282283 |
Brand name | MYLAN-RISPERIDONE |
Common or Proper name | RISPERIDONE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 3.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-07-11 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-10-02 |
Shortage status | Resolved |
Updated date | 2017-10-03 |
Company comments | Discontinuation reported under ID 16166. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2017-10-03 | English | Compare |
v10 | 2017-10-02 | French | Compare |
v9 | 2017-10-02 | English | Compare |
v8 | 2017-07-12 | English | Compare |
v7 | 2017-06-29 | French | Compare |
v6 | 2017-06-29 | English | Compare |
v5 | 2017-05-19 | French | Compare |
v4 | 2017-05-19 | English | Compare |
v3 | 2017-05-04 | French | Compare |
v2 | 2017-05-04 | English | Compare |
v1 | 2017-05-04 | English | Compare |
Showing 1 to 11 of 11